Aldatu Biosciences is changing infectious disease treatment paradigms through innovative diagnostic solutions.
Aldatu Biosciences is a Boston, MA-based, early-stage biotechnology company developing innovative diagnostic tools based on its proprietary genotyping platform, PANDAA. Aldatu is committed to commercializing products that address diagnostic challenges in global health, primarily in HIV and other infectious diseases, and which improve both the quality of patient care and healthcare cost-efficiency.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Feb 8, 2017 | Grant | $3M | 1 | National Institutes of Health | — | Detail |
Feb 23, 2016 | Convertable Note | $100K | 1 | — | — | Detail |
Jun 1, 2015 | Grant | $1.50M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
National Institutes of Health | Yes | Grant |
CH Innovations | — | Convertable Note |